Literature DB >> 389503

Hereditary C2 deficiency associated with non-systemic glomerulonephritis.

A T Sobel, M Moisy, G Hirbec, A Tournesac, J P Berry, P Mannoni, A P Peltier, G Lagrue.   

Abstract

A patient with non-systemic idiopathic glomerulonephritis was found to have a complete deficiency of C2, the second component of complement. The clinical course, histological findings and serological abnormalities are reported in detail. The renal disease was a mild glomerulonephritis with mesangial and subendothelial immune deposits comprising IgG, IgM and C3, increased mesangial matrix without significant cell proliferation. An immunogenetic analysis of the patient's family was carried out. It was demonstrated that the homozygous C2 deficiency was associated with heterozygotism for HLA-A, B and D. Only one of the C2 deficient genes was associated with the expected HLA-A10, B18 haplotype and the propositus was HLA-D2 negative. This report confirms the fact that non-systemic glomerulonephritis should be included in the variety of immunological disorders associated with a complement deficient state. However, C2 deficiency does not seem to be related specifically to a given histological variety of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389503

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

Review 1.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

2.  Renal transplantation in a patient with hereditary deficiency of the second component of complement.

Authors:  H J Zeitz; A Gewurz; O Jonasson; W P Geis; H Gewurz
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

3.  Complement interaction with trypanosomatid promastigotes in normal human serum.

Authors:  Mercedes Domínguez; Inmaculada Moreno; Margarita López-Trascasa; Alfredo Toraño
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.